• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期糖基化终末产物戊糖苷和N-ε-羧甲基赖氨酸在骨质疏松症患者血清中升高。

Advanced glycation end-products pentosidine and N epsilon-carboxymethyllysine are elevated in serum of patients with osteoporosis.

作者信息

Hein G, Wiegand R, Lehmann G, Stein G, Franke S

机构信息

Friedrich-Schiller-University of Jena, Department of Internal Medicine, Germany.

出版信息

Rheumatology (Oxford). 2003 Oct;42(10):1242-6. doi: 10.1093/rheumatology/keg324. Epub 2003 May 30.

DOI:10.1093/rheumatology/keg324
PMID:12777635
Abstract

OBJECTIVE

To investigate serum levels of the advanced glycation end-products (AGEs) pentosidine and N epsilon-carboxymethyllysine (CML) in patients classified into different osteoporosis subgroups according to histomorphometric data.

METHOD

Serum samples were obtained from 116 osteoporotic patients (34 men, 82 women) classified by bone histomorphometry into subgroups with high turnover (HTO, n = 32), low turnover (LTO, n = 39), normal turnover (NTO, n = 9) and cellular uncoupled osteoporosis (CUO, n = 36). Pentosidine was measured by high-performance liquid chromatography, and CML by a competitive enzyme-linked immunoassay.

RESULTS

The entire osteoporosis group had significantly higher pentosidine and CML serum concentrations than healthy subjects. In contrast to healthy subjects, no correlation between levels of AGEs and age could be found. In subgroups characterized by increased bone resorption (HTO, CUO), serum pentosidine correlated significantly with the histomorphometric marker reflecting osteoclast activity/bone resorption (eroded surface as a percentage of trabecular surface). Moreover, in CUO a strong correlation between pentosidine and the mineral apposition rate was found. Surprisingly, in HTO the levels of CML and percentage of eroded surface were significantly negatively correlated.

CONCLUSION

AGE-modified proteins may be a cause of disturbed bone remodelling in osteoporosis. Our findings do not support the alternative hypothesis that increased AGEs in serum indicate only a more intensive releasing of AGEs in circumstances of increased bone resorption.

摘要

目的

根据组织形态计量学数据,研究不同骨质疏松亚组患者血清中晚期糖基化终产物(AGEs)戊糖苷和N-ε-羧甲基赖氨酸(CML)的水平。

方法

从116例骨质疏松患者(34例男性,82例女性)中采集血清样本,这些患者通过骨组织形态计量学分为高转换型(HTO,n = 32)、低转换型(LTO,n = 39)、正常转换型(NTO,n = 9)和细胞解偶联型骨质疏松(CUO,n = 36)亚组。戊糖苷通过高效液相色谱法测定,CML通过竞争性酶联免疫吸附测定法测定。

结果

整个骨质疏松组的血清戊糖苷和CML浓度显著高于健康受试者。与健康受试者不同,未发现AGEs水平与年龄之间存在相关性。在以骨吸收增加为特征的亚组(HTO,CUO)中,血清戊糖苷与反映破骨细胞活性/骨吸收的组织形态计量学标志物(侵蚀表面占小梁表面的百分比)显著相关。此外,在CUO中发现戊糖苷与矿物质沉积率之间存在强相关性。令人惊讶的是,在HTO中,CML水平与侵蚀表面百分比呈显著负相关。

结论

AGE修饰的蛋白质可能是骨质疏松症中骨重塑紊乱的原因。我们的研究结果不支持另一种假设,即血清中AGEs增加仅表明在骨吸收增加的情况下AGEs释放更为强烈。

相似文献

1
Advanced glycation end-products pentosidine and N epsilon-carboxymethyllysine are elevated in serum of patients with osteoporosis.晚期糖基化终末产物戊糖苷和N-ε-羧甲基赖氨酸在骨质疏松症患者血清中升高。
Rheumatology (Oxford). 2003 Oct;42(10):1242-6. doi: 10.1093/rheumatology/keg324. Epub 2003 May 30.
2
Serum levels of the advanced glycation end products Nepsilon-carboxymethyllysine and pentosidine are not influenced by treatment with the angiotensin receptor II type 1 blocker irbesartan in patients with type 2 diabetic nephropathy and hypertension.在2型糖尿病肾病合并高血压患者中,1型血管紧张素受体阻滞剂厄贝沙坦治疗不会影响晚期糖基化终产物Nε-羧甲基赖氨酸和戊糖苷的血清水平。
Nephron Clin Pract. 2008;108(4):c291-7. doi: 10.1159/000127838. Epub 2008 Apr 24.
3
Advanced glycation end products in children with chronic renal failure and type 1 diabetes.慢性肾衰竭和1型糖尿病患儿体内的晚期糖基化终末产物
Pediatr Nephrol. 2002 May;17(5):316-21. doi: 10.1007/s00467-001-0815-9.
4
Marked increases in macrophage colony-stimulating factor and interleukin-18 in maintenance hemodialysis patients: comparative study of advanced glycation end products, carboxymethyllysine and pentosidine.维持性血液透析患者巨噬细胞集落刺激因子和白细胞介素-18显著升高:晚期糖基化终产物、羧甲基赖氨酸和戊糖苷的比较研究
Nephron. 2002 Apr;90(4):401-7. doi: 10.1159/000054727.
5
Increased serum concentrations of pentosidine are related to presence and severity of coronary artery disease.血清中戊糖苷浓度升高与冠状动脉疾病的存在及严重程度相关。
Thromb Res. 2014 Sep;134(3):633-8. doi: 10.1016/j.thromres.2014.07.008. Epub 2014 Jul 17.
6
Are advanced glycation end products cardiovascular risk factors in patients with CRF?晚期糖基化终末产物是慢性肾衰竭患者的心血管危险因素吗?
Am J Kidney Dis. 2003 Mar;41(3 Suppl 1):S52-6. doi: 10.1053/ajkd.2003.50085.
7
The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction.晚期糖基化终产物及其受体在射血分数保留和降低的心衰患者结局中的作用。
Am Heart J. 2012 Nov;164(5):742-749.e3. doi: 10.1016/j.ahj.2012.07.027.
8
Plasma levels of advanced glycation end products are associated with haemolysis-related organ complications in sickle cell patients.血浆中晚期糖基化终产物水平与镰状细胞病患者与溶血相关的器官并发症有关。
Br J Haematol. 2010 Oct;151(1):62-9. doi: 10.1111/j.1365-2141.2010.08320.x. Epub 2010 Jul 30.
9
Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients.戊糖素作为 2 型糖尿病患者微血管并发症的生物标志物。
Diab Vasc Dis Res. 2013 May;10(3):239-45. doi: 10.1177/1479164112460253. Epub 2012 Oct 22.
10
Elevated serum levels of AGEs, sRAGE, and pentosidine in Tunisian patients with severity of diabetic retinopathy.在患有严重糖尿病视网膜病变的突尼斯患者中,AGEs、sRAGE 和戊糖素的血清水平升高。
Microvasc Res. 2012 Nov;84(3):378-83. doi: 10.1016/j.mvr.2012.07.006. Epub 2012 Jul 24.

引用本文的文献

1
Association of plasma levels of protein-bound advanced glycation end-products and their soluble receptors with bone mineral status in young girls with the restrictive type of anorexia nervosa.患有限制型神经性厌食症的年轻女孩血浆中蛋白结合晚期糖基化终产物及其可溶性受体水平与骨矿物质状态的关联。
Arch Osteoporos. 2025 Aug 27;20(1):116. doi: 10.1007/s11657-025-01554-z.
2
Aging impairs the osteocytic regulation of collagen integrity and bone quality.衰老会损害破骨细胞对胶原蛋白完整性和骨质量的调节作用。
Bone Res. 2024 Feb 26;12(1):13. doi: 10.1038/s41413-023-00303-7.
3
Advanced glycation and glycoxidation end products in bone.
骨中的糖基化终末产物和糖基氧化终末产物。
Bone. 2023 Nov;176:116880. doi: 10.1016/j.bone.2023.116880. Epub 2023 Aug 12.
4
The AGE-RAGE Axis and the Pathophysiology of Multimorbidity in COPD.晚期糖基化终末产物-晚期糖基化终末产物受体轴与慢性阻塞性肺疾病的多病共存病理生理学
J Clin Med. 2023 May 9;12(10):3366. doi: 10.3390/jcm12103366.
5
Preventing Disused Bone Loss through Inhibition of Advanced Glycation End Products.通过抑制晚期糖基化终产物预防废用性骨丢失。
Int J Mol Sci. 2023 Mar 3;24(5):4953. doi: 10.3390/ijms24054953.
6
Accumulation of fluorescent advanced glycation end products and carboxymethyl-lysine in human cortical and trabecular bone.荧光晚期糖基化终末产物和羧甲基赖氨酸在人皮质骨和小梁骨中的积累。
Bone Rep. 2022 Nov 3;17:101634. doi: 10.1016/j.bonr.2022.101634. eCollection 2022 Dec.
7
Association of skin autofluorescence with low bone density/osteoporosis and osteoporotic fractures in type 2 diabetes mellitus.2 型糖尿病皮肤自发荧光与低骨密度/骨质疏松症和骨质疏松性骨折的相关性。
J Diabetes. 2022 Sep;14(9):571-585. doi: 10.1111/1753-0407.13309. Epub 2022 Sep 4.
8
A Prospective Analysis of Skin and Fingertip Advanced Glycation End-Product Devices in Healthy Volunteers.健康志愿者皮肤和指尖晚期糖基化终产物检测设备的前瞻性分析
J Clin Med. 2022 Aug 12;11(16):4709. doi: 10.3390/jcm11164709.
9
Serial Passaging of RAW 264.7 Cells Modulates Intracellular AGE Formation and Downregulates RANKL-Induced In Vitro Osteoclastogenesis.RAW 264.7 细胞的连续传代可调节细胞内 AGE 的形成并下调 RANKL 诱导的体外破骨细胞生成。
Int J Mol Sci. 2022 Feb 21;23(4):2371. doi: 10.3390/ijms23042371.
10
Advanced Glycation End Products (AGEs), Receptor for AGEs, Diabetes, and Bone: Review of the Literature.晚期糖基化终末产物(AGEs)、AGEs受体、糖尿病与骨骼:文献综述
J Endocr Soc. 2019 Jul 10;3(10):1799-1818. doi: 10.1210/js.2019-00160. eCollection 2019 Oct 1.